Akari Therapeutics Plc 10-Q filing
Filed 2026-05-19 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001493152-26-024446
- Form type
- 10-Q
- CIK
- 0001541157
- Primary document
- https://www.sec.gov/Archives/edgar/data/1541157/000149315226024446/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Akari Therapeutics Plc.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-15.8M | - | - |
| Net Income | $-14.5M | - | - |
| Eps Basic | 0 | - | - |
| Eps Diluted | 0 | - | - |
| Cash And Equivalents | $2.8M | - | - |
| Total Assets | $33.9M | - | - |
| Total Liabilities | $19.5M | - | - |
| Shareholders Equity | $14.4M | - | - |
| Operating Cash Flow | $-2.5M | - | - |